AIMS: To evaluate the Royal College of Physicians (RCP) '3 questions' in the assessment of asthma control. METHODS: This was a prospective observational study. Subjects (20 adults and 15 children) were assessed 2-weekly over 12 weeks, with data collection on RCP scores (yes/no for each question, 0-3), lung function, asthma control questionnaire (ACQ), asthma quality of life questionnaires (AQLQ), bronchodilator use, and exhaled nitric oxide level. RESULTS: Between-subject analysis showed that the RCP score correlated strongly with the ACQ (correlation coefficient 0.79, p<0.001), AQLQ (-0.71, p=0.001) and bronchodilator use (0.52, p=0.02) in adults, although in children the correlations were weaker and nonsignificant. Within-subject analysis showed strong correlations between changes in the RCP score and ACQ score in adults (0.67, p<0.001) and children (0.61, p<0.001), between quality of life scores in adults (-0.67, p<0.001) and children (-0.69, p<0.001), and changes in bronchodilator use in adults (0.49, p<0.001) and children (0.48, p<0.001). Weaker or absent correlations existed with lung function and no correlations with exhaled nitric oxide levels. An RCP score of 1 or more identified 89% of occasions when the ACQ was >1. CONCLUSIONS: The RCP 3 questions reliably quantify current asthma control in this dataset, with a negative response to all 3 questions indicating good control. These data support the use of the 3 questions, but larger validation studies are needed.
AIMS: To evaluate the Royal College of Physicians (RCP) '3 questions' in the assessment of asthma control. METHODS: This was a prospective observational study. Subjects (20 adults and 15 children) were assessed 2-weekly over 12 weeks, with data collection on RCP scores (yes/no for each question, 0-3), lung function, asthma control questionnaire (ACQ), asthma quality of life questionnaires (AQLQ), bronchodilator use, and exhaled nitric oxide level. RESULTS: Between-subject analysis showed that the RCP score correlated strongly with the ACQ (correlation coefficient 0.79, p<0.001), AQLQ (-0.71, p=0.001) and bronchodilator use (0.52, p=0.02) in adults, although in children the correlations were weaker and nonsignificant. Within-subject analysis showed strong correlations between changes in the RCP score and ACQ score in adults (0.67, p<0.001) and children (0.61, p<0.001), between quality of life scores in adults (-0.67, p<0.001) and children (-0.69, p<0.001), and changes in bronchodilator use in adults (0.49, p<0.001) and children (0.48, p<0.001). Weaker or absent correlations existed with lung function and no correlations with exhaled nitric oxide levels. An RCP score of 1 or more identified 89% of occasions when the ACQ was >1. CONCLUSIONS: The RCP 3 questions reliably quantify current asthma control in this dataset, with a negative response to all 3 questions indicating good control. These data support the use of the 3 questions, but larger validation studies are needed.
Authors: Michelle M Cloutier; Michael Schatz; Mario Castro; Noreen Clark; H William Kelly; Rita Mangione-Smith; James Sheller; Christine Sorkness; Stuart Stoloff; Peter Gergen Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: Hilary Pinnock; Chris Burton; Stephen Campbell; Kevin Gruffydd-Jones; Kerin Hannon; Gaylor Hoskins; Helen Lester; David Price Journal: Prim Care Respir J Date: 2012-09
Authors: Michael D Cabana; Susan J Kunselman; Sharmilee M Nyenhuis; Michael E Wechsler Journal: J Allergy Clin Immunol Date: 2014-01 Impact factor: 10.793
Authors: Eric Van Ganse; Nathalie Texier; Alexandra L Dima; Laurent Laforest; Montserrat Ferrer; Gimena Hernandez; Stéphane Schuck; Sandrine Herbage; Delphine Vial; Marijn de Bruin Journal: NPJ Prim Care Respir Med Date: 2015-06-18 Impact factor: 2.871
Authors: Glen Andrews; David K H Lo; Matthew Richardson; Andrew Wilson; Erol A Gaillard Journal: NPJ Prim Care Respir Med Date: 2018-10-24 Impact factor: 2.871
Authors: Deborah Morrison; Frances S Mair; Rekha Chaudhuri; Marilyn McGee-Lennon; Mike Thomas; Neil C Thomson; Lucy Yardley; Sally Wyke Journal: BMC Med Inform Decis Mak Date: 2015-07-28 Impact factor: 2.796
Authors: Philip E Silkoff; Mark Sarno; Solomon Ssenyange; Vivek Balasubramanyam; Brian Awabdy; Ryan Leard Journal: BMC Pulm Med Date: 2020-05-14 Impact factor: 3.317